Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Trial of Ralinepag in Pulmonary Arterial Hypertension
2014-000667-40Phase 2Completed
- Sponsor
- Arena Pharmaceuticals, Inc.
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pulmonary arterial hypertension (PAH) comparing Ralinepag with Placebo (2 arms). Primary endpoints: Hemodynamic effects of ralinepag and Change in 6-minute walk distance. Started Jan 2015; status: completed.
02
Drugs
ralinepag
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2014-000667-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000667-40.